Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Abivax S.A.

Start price
Target price
Perf. (%)
€25.50
01.12.21
€28.00
01.12.22
-31.92%
20.05.22

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Edap Tms S.A. ADR

Start price
Target price
Perf. (%)
€5.00
03.01.22
-
03.01.23
27.00%
15.05.22

Probably not worthwhile Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€28.30
27.11.21
€28.00
27.11.22
-44.88%
30.03.22

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€3.04
20.02.22
€4.00
20.03.22
-11.39%
21.03.22

Could be worthwhile Investment >10% per year
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.80
05.09.21
-
05.09.22
-47.79%
07.03.22

Probably not worthwhile Investment
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€4.07
15.02.22
€5.00
15.03.22
-25.36%
20.02.22

Could be worthwhile Investment >10% per year
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€5.37
24.11.21
€6.00
24.11.22
-24.21%
15.02.22

Could be worthwhile Investment >10% per year
buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.51
01.02.22
€4.15
01.02.23
-7.69%
10.02.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.90
23.01.22
-
23.01.23
-5.47%
06.02.22

Could be very worthwhile Investment >20% year
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.12
10.01.22
-
10.01.23
-14.85%
01.02.22

Could be worthwhile Investment >10% per year
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€8.16
15.01.21
-
15.01.22
-63.58%
16.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.03
04.01.22
-
04.01.23
-7.46%
07.01.22

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Valneva SE

Start price
Target price
Perf. (%)
€12.34
13.09.21
€9.00
13.09.22
100.65%
16.12.21

Could be very worthwhile Investment >20% year
Abivax S.A.

Start price
Target price
Perf. (%)
€30.50
28.06.21
€25.00
28.06.22
-16.39%
01.12.21

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Valneva SE

Start price
Target price
Perf. (%)
€11.84
13.09.21
-
13.09.22
139.19%
29.11.21

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
buy
Valneva SE

Start price
Target price
Perf. (%)
€21.24
15.11.21
€25.00
15.11.22
33.24%
27.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Boiron S.A.

Start price
Target price
Perf. (%)
€38.55
13.04.21
€36.00
13.04.22
-1.30%
26.11.21

Could be worthwhile Investment >10% per year
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€10.08
09.10.21
€12.00
09.10.22
-20.04%
26.11.21

Could be worthwhile Investment >10% per year
Valneva SE

Start price
Target price
Perf. (%)
€24.38
25.11.21
€21.00
25.11.22
6.64%
26.11.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.24
20.07.21
€20.00
20.07.22
116.90%
25.11.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€5.86
07.10.21
€7.50
07.10.22
-8.28%
24.11.21

Could be worthwhile Investment >10% per year
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.24
17.11.21
€1.80
17.11.22
0.00%
19.11.21

Could be worthwhile Investment >10% per year
buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.19
11.11.21
-
11.11.22
2.28%
17.11.21

Could be worthwhile Investment >10% per year